Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Harada

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Cellular Immunology|September 12, 2006
Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patientsYi Wang, Yukari Takao, Mamoru Harada, et al.
Japanese Journal of Cancer Research : Gann|May 3, 2002
Elevation of serum MAGE-4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosisShigeru Yutani, Masatoshi Tanaka, Hajime Mutsumoto, et al.
The Prostate|April 19, 2007
Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancerMasanori Noguchi, Akihisa Yao, Mamoru Harada, et al.
International Journal of Oncology|November 8, 2006
Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
Microbiology and Immunology|November 23, 2006
New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patientsYi Wang, Yukari Takao, Mamoru Harada, et al.
Asian Pacific Journal of Allergy and Immunology|December 6, 2008
A correlation between symptom severity and unbalanced reactive IgA production in Japanese cedar pollinosis patientsNobukazu Komatsu, Mamoru Harada, Masami Nakagawa, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Expression of epithelial cancer-related antigens in hematologic malignancies applicable for peptide-based immunotherapyHiroko Takedatsu, Takashi Okamura, Kohji Yoshimoto, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2006
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype allelesTakafumi Minami, Satoko Matsueda, Hiroko Takedatsu, et al.
Cancer Science|April 2, 2020
Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cellsTamio Okimoto, Hitoshi Kotani, Yuichi Iida, et al.
Oncotarget|October 22, 2014
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibitionHiroki Tamaki, Nanae Harashima, Miho Hiraki, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Cellular Immunology|September 12, 2006
Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patientsYi Wang, Yukari Takao, Mamoru Harada, et al.
Japanese Journal of Cancer Research : Gann|May 3, 2002
Elevation of serum MAGE-4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosisShigeru Yutani, Masatoshi Tanaka, Hajime Mutsumoto, et al.
The Prostate|April 19, 2007
Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancerMasanori Noguchi, Akihisa Yao, Mamoru Harada, et al.
International Journal of Oncology|November 8, 2006
Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
Microbiology and Immunology|November 23, 2006
New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patientsYi Wang, Yukari Takao, Mamoru Harada, et al.
Asian Pacific Journal of Allergy and Immunology|December 6, 2008
A correlation between symptom severity and unbalanced reactive IgA production in Japanese cedar pollinosis patientsNobukazu Komatsu, Mamoru Harada, Masami Nakagawa, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Expression of epithelial cancer-related antigens in hematologic malignancies applicable for peptide-based immunotherapyHiroko Takedatsu, Takashi Okamura, Kohji Yoshimoto, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2006
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype allelesTakafumi Minami, Satoko Matsueda, Hiroko Takedatsu, et al.
Cancer Science|April 2, 2020
Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cellsTamio Okimoto, Hitoshi Kotani, Yuichi Iida, et al.
Oncotarget|October 22, 2014
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibitionHiroki Tamaki, Nanae Harashima, Miho Hiraki, et al.
Pageof 11